Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
National University Corporation Shiga University Of Medical Science is managing 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 4 pending matters are assigned to 4 distinct examiners, ensuring that no single examiner has a majority influence over the current portfolio. However, these examiners are situated within only 2 distinct art units, indicating that the university's research is focused on a few specific technical domains.
The busiest examiner identified is MEYERING, SHABANA SHABBEER, who is responsible for 1 busiest examiner pending office action. With 4 pending office actions total, the university faces a diverse set of examiner perspectives within a concentrated set of art units. This scenario requires practitioners to adapt to four different individual styles while maintaining a consistent technical argument suitable for the standards of the two active art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MEYERING, SHABANA SHABBEER | 1 | 70.6% | +42.3% |
| OLSON, ANDREA STEFFEL | 1 | 62.3% | -11.9% |
| BOLER, RYNAE E | 1 | 62.4% | +8.8% |
| ZHU, JIANJIAN | 1 | 58.8% | +82.4% |
| MIANO, JOSEPH PAUL | 1 | 36.0% | +63.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17262400 | METHOD FOR PRODUCING FOREIGN ANTIGEN RECEPTOR GENE-INTRODUCED CELL | MIANO, JOSEPH PAUL | 87d overdue |
| 18688563 | PHARMACEUTICAL COMPOSITION UTILIZING BORNAVIRUS VECTOR | MEYERING, SHABANA SHABBEER | — |
| 18576858 | TISSUE FORMATION AGENT | OLSON, ANDREA STEFFEL | — |
| 18143451 | MOVABLE ELONGATED STRUCTURE AND METHOD | BOLER, RYNAE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17262400 | METHOD FOR PRODUCING FOREIGN ANTIGEN RECEPTOR GENE-INTRODUCED CELL | MIANO, JOSEPH PAUL | 87d overdue |
| 18027306 | METHOD FOR PREPARING EFFECTOR CELLS WITH DESIRED SPECIFICITY | ZHU, JIANJIAN | 2d overdue |
| 18688563 | PHARMACEUTICAL COMPOSITION UTILIZING BORNAVIRUS VECTOR | MEYERING, SHABANA SHABBEER | — |
| Art Unit | Apps |
|---|---|
| 1631 | 2 |
| 1693 | 1 |
| 3795 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18688563 | PHARMACEUTICAL COMPOSITION UTILIZING BORNAVIRUS VECTOR | MEYERING, SHABANA SHABBEER | — | §101§103§112 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18576858 | TISSUE FORMATION AGENT | OLSON, ANDREA STEFFEL | 1693 | §102§103 | Final Rejection | — | Pending | Jan 05, 2024 |
| 18143451 | MOVABLE ELONGATED STRUCTURE AND METHOD | BOLER, RYNAE E | 3795 | §102§103§112 | Non-Final OA | — | Pending | May 04, 2023 |
| 18027306 | METHOD FOR PREPARING EFFECTOR CELLS WITH DESIRED SPECIFICITY | ZHU, JIANJIAN | 1631 | §103§112DP | Final Rejection | 2d overdue | Pending | Mar 20, 2023 |
| 17262400 | METHOD FOR PRODUCING FOREIGN ANTIGEN RECEPTOR GENE-INTRODUCED CELL | MIANO, JOSEPH PAUL | 1631 | §102§103§112Other | Non-Final OA | 87d overdue | Pending | Aug 27, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial